• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PHENOTYPIC SWITCHING OF VASCULAR SMOOTH MUSCLE CELLS: KEY MECHANISM IN ATHEROSCLEROSIS PROGRESSION.

作者信息

Chigareva I, Karelova A, Zeinalova N, Abdulkhadzhiev A, Isaev A, Kurbanov G, Israpilov I, Dagaeva I, Dashaeva M, Petchina A, Delimkhanov R, Musaev E, Pandyashkina K

机构信息

1North-Western State Medical University named after I.I. Mechnikov, Saint-Petersburg, Russia.

2Kadyrov Chechen State University, Grozny, Russia.

出版信息

Georgian Med News. 2025 Apr(361):54-58.

PMID:40694698
Abstract

Vascular smooth muscle cells (VSMCs) have emerged as key contributors to atherosclerosis through their remarkable phenotypic plasticity. In response to vascular injury, inflammation, and metabolic stress, VSMCs transition from a differentiated contractile phenotype to a synthetic, proliferative, and migratory state. Recent evidence reveals that VSMCs also transdifferentiate into macrophage-like, osteogenic, and mesenchymal-like phenotypes, actively shaping plaque composition and stability. This review provides a comprehensive analysis of the molecular mechanisms underlying VSMC phenotypic modulation, including PDGF-BB, TGF-β, KLF4, TCF21, and non-coding RNAs. We also explore the dual roles of VSMCs in promoting vascular repair and contributing to disease progression. Understanding these processes offers novel insights into plaque pathobiology and presents promising therapeutic targets to stabilize atherosclerotic lesions and prevent adverse cardiovascular events.

摘要

相似文献

1
PHENOTYPIC SWITCHING OF VASCULAR SMOOTH MUSCLE CELLS: KEY MECHANISM IN ATHEROSCLEROSIS PROGRESSION.
Georgian Med News. 2025 Apr(361):54-58.
2
Six Shades of Vascular Smooth Muscle Cells Illuminated by KLF4 (Krüppel-Like Factor 4).KLF4(Krüppel 样因子 4)揭示血管平滑肌细胞的六种色调。
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2693-2707. doi: 10.1161/ATVBAHA.121.316600. Epub 2021 Sep 2.
3
microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.miRNA let-7g 抑制 PDGF 诱导的血管平滑肌细胞向合成表型的转化。
J Cell Mol Med. 2017 Dec;21(12):3592-3601. doi: 10.1111/jcmm.13269. Epub 2017 Jul 12.
4
NEXN regulates vascular smooth muscle cell phenotypic switching and neointimal hyperplasia.NEXN调节血管平滑肌细胞表型转换和内膜增生。
JCI Insight. 2025 May 29;10(13). doi: 10.1172/jci.insight.190089. eCollection 2025 Jul 8.
5
Insulin receptors in vascular smooth muscle cells regulate plaque stability of atherosclerosis.血管平滑肌细胞中的胰岛素受体调节动脉粥样硬化斑块的稳定性。
Cardiovasc Res. 2024 Dec 14;120(16):2017-2030. doi: 10.1093/cvr/cvae193.
6
Lipid infiltration promotes trans-differentiation of vascular smooth muscle cells into macrophage-like cells in early lesions of human coronary atherosclerosis.脂质浸润在人类冠状动脉粥样硬化早期病变中促进血管平滑肌细胞向巨噬细胞样细胞转分化。
Lipids Health Dis. 2025 Jul 14;24(1):239. doi: 10.1186/s12944-025-02662-y.
7
RNA splicing of the STAT3 by PCBP1 promotes vulnerable plaque formation via macrophage-like phenotype modulation of vascular smooth muscle cell.PCBP1对STAT3进行的RNA剪接通过调节血管平滑肌细胞的巨噬细胞样表型促进易损斑块形成。
Atherosclerosis. 2025 Mar;402:119128. doi: 10.1016/j.atherosclerosis.2025.119128. Epub 2025 Feb 2.
8
Scoparone alleviates aortic aneurysm formation by inhibiting smooth muscle cell phenotypic switching and inflammation via mTOR suppression.滨蒿内酯通过抑制mTOR来抑制平滑肌细胞表型转换和炎症反应,从而减轻主动脉瘤的形成。
J Ethnopharmacol. 2025 Jun 7;351:120080. doi: 10.1016/j.jep.2025.120080.
9
Deletion of smooth muscle ZFP36 promotes neointimal hyperplasia in mice.平滑肌ZFP36的缺失促进小鼠血管内膜增生。
Acta Pharmacol Sin. 2025 May;46(5):1317-1328. doi: 10.1038/s41401-024-01473-8. Epub 2025 Jan 31.
10
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis.血管平滑肌细胞:动脉粥样硬化的治疗靶点
Rev Cardiovasc Med. 2025 Jun 26;26(6):28240. doi: 10.31083/RCM28240. eCollection 2025 Jun.